Congress has supported NIH funding for the current fiscal year, but issues around key types of funding remain.

UCSF scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic MS.

UCSF Chancellor Sam Hawgood will announce a significant step toward ensuring the future of UCSF during his annual State of the University address on Oct. 27.

Study shows, over the course of 19 years, the hard core group smoked progressively fewer cigarettes per day and tried to quit in increasingly greater numbers, along with every other group of smokers in the US.

Atul Butte has been appointed to the Governor’s Advisory Committee on Precision Medicine, a new group of experts that will contribute to the state’s continuing efforts to use advanced computing and technology to better understand, treat and prevent disease.

Deepak Srivastava has been appointed president of Gladstone Institutes. His term will begin on Jan. 1, 2018.

Two UCSF scientists have been awarded NIH New Innovator Awards, which support unusually innovative research from early career investigators.

UCSF researcher Saul Kato is using a new high-resolution whole-brain imaging technique to see how the entire nervous system of a worm works together to generate behavior.